These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

446 related items for PubMed ID: 28290604

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Endogenous GLP-1 as a key self-defense molecule against lipotoxicity in pancreatic islets.
    Huang C, Yuan L, Cao S.
    Int J Mol Med; 2015 Jul; 36(1):173-85. PubMed ID: 25976560
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Distinct effects of dipeptidyl peptidase-4 inhibitor and glucagon-like peptide-1 receptor agonist on islet morphology and function.
    Morita A, Mukai E, Hiratsuka A, Takatani T, Iwanaga T, Lee EY, Miki T.
    Endocrine; 2016 Mar; 51(3):429-39. PubMed ID: 26349938
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Liraglutide Enhances Autophagy and Promotes Pancreatic β Cell Proliferation to Ameliorate Type 2 Diabetes in High-Fat-Fed and Streptozotocin-Treated Mice.
    Fan M, Jiang H, Zhang Y, Ma Y, Li L, Wu J.
    Med Sci Monit; 2018 Apr 17; 24():2310-2316. PubMed ID: 29664069
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effects of GLP-1RA and SGLT2i, Alone or in Combination, on Mouse Models of Type 2 Diabetes Representing Different Disease Stages.
    Koike M, Saito H, Kohno G, Takubo M, Watanabe K, Ishihara H.
    Int J Mol Sci; 2021 Oct 25; 22(21):. PubMed ID: 34768897
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Activation of GLP-1 receptor signalling alleviates cellular stresses and improves beta cell function in a mouse model of Wolfram syndrome.
    Kondo M, Tanabe K, Amo-Shiinoki K, Hatanaka M, Morii T, Takahashi H, Seino S, Yamada Y, Tanizawa Y.
    Diabetologia; 2018 Oct 25; 61(10):2189-2201. PubMed ID: 30054673
    [Abstract] [Full Text] [Related]

  • 14. Long-term liraglutide treatment is associated with increased insulin content and secretion in β-cells, and a loss of α-cells in ZDF rats.
    Schwasinger-Schmidt T, Robbins DC, Williams SJ, Novikova L, Stehno-Bittel L.
    Pharmacol Res; 2013 Oct 25; 76():58-66. PubMed ID: 23891763
    [Abstract] [Full Text] [Related]

  • 15. beta-cell failure in diabetes and preservation by clinical treatment.
    Wajchenberg BL.
    Endocr Rev; 2007 Apr 25; 28(2):187-218. PubMed ID: 17353295
    [Abstract] [Full Text] [Related]

  • 16. Liraglutide and sitagliptin counter beta- to alpha-cell transdifferentiation in diabetes.
    Tanday N, Flatt PR, Irwin N, Moffett RC.
    J Endocrinol; 2020 Apr 25; 245(1):53-64. PubMed ID: 31977315
    [Abstract] [Full Text] [Related]

  • 17. SREBP-1c, Pdx-1, and GLP-1R involved in palmitate-EPA regulated glucose-stimulated insulin secretion in INS-1 cells.
    Shao S, Liu Z, Yang Y, Zhang M, Yu X.
    J Cell Biochem; 2010 Oct 15; 111(3):634-42. PubMed ID: 20589757
    [Abstract] [Full Text] [Related]

  • 18. Human embryonic stem cell differentiation into insulin secreting β-cells for diabetes.
    Bose B, Shenoy SP, Konda S, Wangikar P.
    Cell Biol Int; 2012 Nov 01; 36(11):1013-20. PubMed ID: 22897387
    [Abstract] [Full Text] [Related]

  • 19. Puerarin Protects Pancreatic β-Cells in Obese Diabetic Mice via Activation of GLP-1R Signaling.
    Yang L, Yao D, Yang H, Wei Y, Peng Y, Ding Y, Shu L.
    Mol Endocrinol; 2016 Mar 01; 30(3):361-71. PubMed ID: 26789107
    [Abstract] [Full Text] [Related]

  • 20. Liraglutide prevents β-cell apoptosis via inactivation of NOX2 and its related signaling pathway.
    Ding M, Fang QH, Cui YT, Shen QL, Liu Q, Wang PH, Yu DM, Li CJ.
    J Diabetes Complications; 2019 Apr 01; 33(4):267-277. PubMed ID: 30772113
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.